Although the CD19+CD27+ memory B cells in the peripheral blood of SSc patients were decreased, the expression of their activation markers (CD80, CD95, HLA-DR) changed in the opposite direction (Forestier et al., 2018). This evidence concerns the gene CD19 and systemic sclerosis.